nad has been researched along with 1,n(6)-ethenoadenosine diphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balestrieri, C; Giovane, A; Quagliuolo, L; Servillo, L | 1 |
| Liao, SD; Puro, DG | 1 |
2 other study(ies) available for nad and 1,n(6)-ethenoadenosine diphosphate
| Article | Year |
|---|---|
1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
Topics: Adenosine Diphosphate; Adenosine Diphosphate Ribose; Chromatography; Diphtheria Toxin; Female; Humans; Kinetics; NAD; Nucleoside Diphosphate Sugars; Peptide Elongation Factor 2; Peptide Elongation Factors; Peptide Fragments; Phosphoric Diester Hydrolases; Placenta; Pregnancy; Spectrometry, Fluorescence | 1985 |
NAD+-induced vasotoxicity in the pericyte-containing microvasculature of the rat retina: effect of diabetes.
Topics: Adenosine Diphosphate; Adenosine Diphosphate Ribose; ADP Ribose Transferases; Animals; Apoptosis; Benzoxazoles; Cell Membrane Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Fluorescent Dyes; Microscopy, Fluorescence; NAD; Pericytes; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Rats; Rats, Long-Evans; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Retinal Vessels | 2006 |